top of page

In Conversation with Simon Graindorge, COO at OncoRes Medical

2024 is shaping up to be a pivotal year for OncoRes Medical. As we advance our innovative technology, generating robust evidence that supports regulatory approval and demonstrates our positive impact on patients is a top priority.


In the first installment of our In Conversation series, OncoRes’ Chief Operating Officer, Dr. Simon Graindorge, provides insights into our current clinical trials, timelines for key milestones, and our commitment to fostering medical device innovation in Australia. Take a look:


86 views0 comments

Comentários


bottom of page